ASX - By Stock
|
RAC |
Re:
Ann: Race to Present at TechKnow July Conference
|
|
Rhino1963
|
132 |
30K |
3 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
132
|
30K
|
3
|
|
ASX - By Stock
|
ADN |
Re:
Ann: Quarterly Activities/Appendix 5B Cash Flow Report
|
|
Rhino1963
|
35 |
10K |
12 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
35
|
10K
|
12
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race to Present at TechKnow July Conference
|
|
Rhino1963
|
132 |
30K |
29 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
132
|
30K
|
29
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race to Present at TechKnow July Conference
|
|
Rhino1963
|
132 |
30K |
7 |
27/07/24 |
27/07/24 |
ASX - By Stock
|
132
|
30K
|
7
|
|
ASX - By Stock
|
RAC |
Re:
Race Oncology - Cashflow Forecast to December 2024
|
|
Rhino1963
|
27 |
8.9K |
16 |
27/07/24 |
27/07/24 |
ASX - By Stock
|
27
|
8.9K
|
16
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
Rhino1963
|
881 |
256K |
20 |
22/07/24 |
22/07/24 |
ASX - By Stock
|
881
|
256K
|
20
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
Rhino1963
|
881 |
256K |
8 |
22/07/24 |
22/07/24 |
ASX - By Stock
|
881
|
256K
|
8
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
Rhino1963
|
881 |
256K |
23 |
22/07/24 |
22/07/24 |
ASX - By Stock
|
881
|
256K
|
23
|
|
ASX - By Stock
|
ADN |
Re:
Ann: Binding Offtake Agreement signed with Traxys
|
|
Rhino1963
|
129 |
51K |
4 |
22/07/24 |
22/07/24 |
ASX - By Stock
|
129
|
51K
|
4
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Rhino1963
|
11K |
3.9M |
9 |
19/07/24 |
19/07/24 |
General
|
11K
|
3.9M
|
9
|
|
ASX - By Stock
|
ADN |
Re:
Ann: Binding Offtake Agreement signed with Traxys
|
|
Rhino1963
|
129 |
51K |
7 |
17/07/24 |
17/07/24 |
ASX - By Stock
|
129
|
51K
|
7
|
|
ASX - By Stock
|
ADN |
Re:
Ann: Binding Offtake Agreement signed with Traxys
|
|
Rhino1963
|
129 |
51K |
54 |
17/07/24 |
17/07/24 |
ASX - By Stock
|
129
|
51K
|
54
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Appoints George Clinical for Phase 1 Trial of RC220
|
|
Rhino1963
|
146 |
42K |
5 |
16/07/24 |
16/07/24 |
ASX - By Stock
|
146
|
42K
|
5
|
|
ASX - By Stock
|
RAC |
Re:
RAC - Crystal ball gazing
|
|
Rhino1963
|
38 |
7.7K |
26 |
16/07/24 |
16/07/24 |
ASX - By Stock
|
38
|
7.7K
|
26
|
|
ASX - By Stock
|
RAC |
Re:
RAC - Crystal ball gazing
|
|
Rhino1963
|
38 |
7.7K |
22 |
15/07/24 |
15/07/24 |
ASX - By Stock
|
38
|
7.7K
|
22
|
|
ASX - By Stock
|
RAC |
Re:
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?
|
|
Rhino1963
|
391 |
79K |
15 |
10/07/24 |
10/07/24 |
ASX - By Stock
|
391
|
79K
|
15
|
|
ASX - By Stock
|
RAC |
Re:
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?
|
|
Rhino1963
|
391 |
79K |
24 |
09/07/24 |
09/07/24 |
ASX - By Stock
|
391
|
79K
|
24
|
|
ASX - By Stock
|
RAC |
Re:
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?
|
|
Rhino1963
|
391 |
79K |
8 |
08/07/24 |
08/07/24 |
ASX - By Stock
|
391
|
79K
|
8
|
|
ASX - By Stock
|
RAC |
Re:
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?
|
|
Rhino1963
|
391 |
79K |
7 |
08/07/24 |
08/07/24 |
ASX - By Stock
|
391
|
79K
|
7
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Distinguished Oncologist Daniel Von Hoff Joins as Consultant
|
|
Rhino1963
|
168 |
46K |
7 |
07/07/24 |
07/07/24 |
ASX - By Stock
|
168
|
46K
|
7
|
|
ASX - By Stock
|
RAC |
Re:
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?
|
|
Rhino1963
|
391 |
79K |
31 |
07/07/24 |
07/07/24 |
ASX - By Stock
|
391
|
79K
|
31
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race In-person Investor Briefing Invitation Perth
|
|
Rhino1963
|
130 |
36K |
4 |
04/07/24 |
04/07/24 |
ASX - By Stock
|
130
|
36K
|
4
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race In-person Investor Briefing Invitation Perth
|
|
Rhino1963
|
130 |
36K |
38 |
04/07/24 |
04/07/24 |
ASX - By Stock
|
130
|
36K
|
38
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Distinguished Oncologist Daniel Von Hoff Joins as Consultant
|
|
Rhino1963
|
168 |
46K |
9 |
03/07/24 |
03/07/24 |
ASX - By Stock
|
168
|
46K
|
9
|
|
ASX - By Stock
|
RAC |
Re:
Industry news
|
|
Rhino1963
|
1.8K |
654K |
6 |
01/07/24 |
01/07/24 |
ASX - By Stock
|
1.8K
|
654K
|
6
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Rhino1963
|
11K |
3.9M |
10 |
01/07/24 |
01/07/24 |
General
|
11K
|
3.9M
|
10
|
|
ASX - By Stock
|
RAC |
Re:
Industry news
|
|
Rhino1963
|
1.8K |
654K |
53 |
30/06/24 |
30/06/24 |
ASX - By Stock
|
1.8K
|
654K
|
53
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Rhino1963
|
21K |
7.5M |
3 |
28/06/24 |
28/06/24 |
ASX - By Stock
|
21K
|
7.5M
|
3
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Rhino1963
|
21K |
7.5M |
12 |
28/06/24 |
28/06/24 |
ASX - By Stock
|
21K
|
7.5M
|
12
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Rhino1963
|
11K |
3.9M |
16 |
25/06/24 |
25/06/24 |
General
|
11K
|
3.9M
|
16
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
Rhino1963
|
881 |
256K |
5 |
23/06/24 |
23/06/24 |
ASX - By Stock
|
881
|
256K
|
5
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
Rhino1963
|
881 |
256K |
32 |
23/06/24 |
23/06/24 |
ASX - By Stock
|
881
|
256K
|
32
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
Rhino1963
|
881 |
256K |
43 |
23/06/24 |
23/06/24 |
ASX - By Stock
|
881
|
256K
|
43
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
Rhino1963
|
881 |
256K |
26 |
22/06/24 |
22/06/24 |
ASX - By Stock
|
881
|
256K
|
26
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Rhino1963
|
21K |
7.5M |
24 |
21/06/24 |
21/06/24 |
ASX - By Stock
|
21K
|
7.5M
|
24
|
|
ASX - By Stock
|
RAC |
Re:
Industry news
|
|
Rhino1963
|
1.8K |
654K |
5 |
20/06/24 |
20/06/24 |
ASX - By Stock
|
1.8K
|
654K
|
5
|
|
ASX - By Stock
|
RAC |
Re:
Industry news
|
|
Rhino1963
|
1.8K |
654K |
6 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
1.8K
|
654K
|
6
|
|
ASX - By Stock
|
RAC |
Re:
Ann: US FDA Orphan Drug Designation Awarded to RC220 Bisantrene
|
|
Rhino1963
|
110 |
37K |
6 |
18/06/24 |
18/06/24 |
ASX - By Stock
|
110
|
37K
|
6
|
|
ASX - By Stock
|
RAC |
Re:
Ann: FDA RPD Designation Granted for RC220 Bisantrene
|
|
Rhino1963
|
80 |
25K |
45 |
18/06/24 |
18/06/24 |
ASX - By Stock
|
80
|
25K
|
45
|
|
ASX - By Stock
|
RAC |
Re:
Ann: FDA RPD Designation Granted for RC220 Bisantrene
|
|
Rhino1963
|
80 |
25K |
21 |
18/06/24 |
18/06/24 |
ASX - By Stock
|
80
|
25K
|
21
|
|
ASX - By Stock
|
RAC |
Re:
Speculative M&A Transaction Analysis
|
|
Rhino1963
|
740 |
278K |
11 |
16/06/24 |
16/06/24 |
ASX - By Stock
|
740
|
278K
|
11
|
|
ASX - By Stock
|
RAC |
Re:
Speculative M&A Transaction Analysis
|
|
Rhino1963
|
740 |
278K |
21 |
16/06/24 |
16/06/24 |
ASX - By Stock
|
740
|
278K
|
21
|
|
ASX - By Stock
|
RAC |
Re:
Speculative M&A Transaction Analysis
|
|
Rhino1963
|
740 |
278K |
40 |
16/06/24 |
16/06/24 |
ASX - By Stock
|
740
|
278K
|
40
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Rhino1963
|
11K |
3.9M |
30 |
15/06/24 |
15/06/24 |
General
|
11K
|
3.9M
|
30
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Rhino1963
|
21K |
7.5M |
10 |
14/06/24 |
14/06/24 |
ASX - By Stock
|
21K
|
7.5M
|
10
|
|
ASX - By Stock
|
RAC |
Re:
Chat GPT Q&A
|
|
Rhino1963
|
196 |
72K |
40 |
10/06/24 |
10/06/24 |
ASX - By Stock
|
196
|
72K
|
40
|
|
ASX - By Stock
|
RAC |
Re:
Chat GPT Q&A
|
|
Rhino1963
|
196 |
72K |
22 |
10/06/24 |
10/06/24 |
ASX - By Stock
|
196
|
72K
|
22
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bonus Options Offer Results
|
|
Rhino1963
|
35 |
12K |
4 |
06/06/24 |
06/06/24 |
ASX - By Stock
|
35
|
12K
|
4
|
|
ASX - By Stock
|
ADN |
Re:
General comments/chat
|
|
Rhino1963
|
44K |
21M |
10 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
44K
|
21M
|
10
|
|
ASX - By Stock
|
RAC |
Re:
[WEBINAR REPLAY] What it takes to get a new drug to market in Australia
|
|
Rhino1963
|
37 |
9.0K |
37 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
37
|
9.0K
|
37
|
|